XARELTO®: Deep vein thrombosis (DVT) prophylaxis after hip or knee replacement surgery

Proven efficacy and safety profile in DVT prophylaxis after hip or knee replacement surgery

DVT PROPHYLAXIS DOSING Convenient, once-daily* oral dosing

DVT PROPHYLAXIS EFFICACY Significantly lower rates of total VTE versus enoxaparin after hip or knee replacement surgery1-3

DVT PROPHYLAXIS SAFETY Similar rates of bleeding versus enoxaparin after hip/knee replacement surgery1-3

DVT PROPHYLAXIS CLINICAL TRIALS Time and time again—extensive clinical and real-world evidence1-4

FORMULARY FINDER Coverage for your patients

JANSSEN CAREPATH XARELTO® Savings Program

DVT Prophylaxis Resources

DOSING ACROSS INDICATIONS Condition-specific dosing for XARELTO®

RECORD1 Eriksson BI et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty

ORS WELCOME KIT Your patient’s guide to starting treatment for ORS

View all resources

*Taken with evening meal.

References: 1. Eriksson BI, Borris LC, Friedman RJ, et al; RECORD1 Study Group. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med. 2008;358(26):2765-2775. 2. Kakkar AK, Brenner B, Dahl OE, et al; RECORD2 Investigators. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet. 2008;372(9632):31-39. 3. Lassen MR, Ageno W, Borris LC, et al; RECORD3 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008;358(26):2776-2786. 4. Turpie AGG, Haas S, Kreutz R, et al. A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment. Thromb Haemost. 2014;111(1):94-102.